pocketful logo light
pocketful logo light
Shelter Pharma Ltd logo

Shelter Pharma Ltd

NSE: BSE: 543963

₹32.20

(7.33%)

Tue, 09 Jun 2026, 02:26 am

Shelter Pharma Ratios

No Result Found

Particulars
Price to earnings ratio
Price to book ratio
Price to sales ratio
Price to cash flow ratio
Enterprise value
Enterprise value to EBITDA ratio
Debt to equity ratio
Return on equity %

Shelter Pharma Ltd Ratios

The Shelter Pharma Ltd Ratios page provides a complete fundamental analysis of Shelter Pharma Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Shelter Pharma Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Shelter Pharma Ltd (NSE: , BSE: 543963) is currently trading at ₹32.20, with a market capitalization of ₹0. As a major player in the Health technology sector and Pharmaceuticals: major industry, Shelter Pharma Ltd remains a key stock for fundamental analysis using Shelter Pharma Ltd Ratios.

Shelter Pharma Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Shelter Pharma Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Shelter Pharma Ltd Ratios.

Historically, the Shelter Pharma Ltd P/E ratio has shown strong fluctuations:

    The decline in Shelter Pharma Ltd P/E ratio suggests improving earnings relative to stock price.

    Price to Book Ratio (P/B)

    The Shelter Pharma Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.

    Historical P/B trend:

      Shelter Pharma Ltd shows reasonable valuation compared to its asset base.

      Price to Sales Ratio (P/S)

      The Shelter Pharma Ltd P/S ratio currently stands at 0, an important part of Shelter Pharma Ltd Ratios for revenue valuation.

      Historical P/S ratio:

        A stable or declining Shelter Pharma Ltd P/S ratio indicates cautious market sentiment.

        Shelter Pharma Ltd Price to Cash Flow Ratio (P/CF)

        The Shelter Pharma Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

        Historical Shelter Pharma Ltd Price to Cash Flow Ratio:

          The declining Shelter Pharma Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

          Shelter Pharma Ltd Enterprise Value Ratios

          Enterprise Value (EV)

          The Shelter Pharma Ltd EV currently stands at ₹0, representing the total company valuation including debt.

          Historical EV trend:

            Shelter Pharma Ltd enterprise value consolidation suggests stable valuation.

            EV/EBITDA Ratio

            The Shelter Pharma Ltd EV/EBITDA ratio is currently 0, a key metric in Shelter Pharma Ltd Ratios to assess valuation relative to earnings.

            Historical EV/EBITDA:

              Stable Shelter Pharma Ltd EV/EBITDA indicates balanced valuation.

              Shelter Pharma Ltd Financial Strength Ratios

              Debt to Equity Ratio (D/E)

              The Shelter Pharma Ltd D/E ratio is currently 0, reflecting leverage and financial stability.

              Historical D/E:

                Shelter Pharma Ltd maintains a strong balance sheet with low debt levels.

                Return on Equity (ROE %)

                The Shelter Pharma Ltd ROE currently stands at 0%, showing profitability and capital efficiency.

                Historical ROE:

                  Declining ROE indicates pressure on profitability.

                  Shelter Pharma Ltd Ratios Analysis Summary

                  The Shelter Pharma Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Shelter Pharma Ltd stock is undervalued, fairly valued, or overvalued.

                  Tracking Shelter Pharma Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.